Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34+ progenitors

Journal of General Virology

Volumn 92, Issue 7, 2011, Pages 1539-1549

  Poole, Emma ^a   Dallas, Stuart R McGregor ^a   Colston, Julia ^a   Joseph, Robert Samuel V ^a   Sinclair, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MICRORNA; TRANSCRIPTION FACTOR GATA 2;

ARTICLE; CD34 SELECTION; GENE EXPRESSION; GENETIC SCREENING; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENOME; VIRUS INDUCTION; VIRUS LATENCY; VIRUS SURVIVAL;

ANTIGENS, CD34; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICRORNAS; VIRUS LATENCY;

HUMAN HERPESVIRUS 5;

EID: 79959309652     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.031377-0     Document Type: Article

References (58)

1. Baillie, J., Sahlender, D. A. & Sinclair, J. H. (2003). Human cytomegalovirus infection inhibits tumor necrosis factor alpha (TNF-a) signaling by targeting the 55-kilodalton TNF-a receptor. J Virol 77, 7007-7016.
2. Bego, M., Maciejewski, J., Khaiboullina, S., Pari, G. & St Jeor, S. (2005). Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J Virol 79, 11022-11034.
3. Bennasser, Y., Le, S. Y., Yeung, M. L. & Jeang, K. T. (2006). MicroRNAs in human immunodeficiency virus-1 infection. Methods Mol Biol 342, 241-253.
4. Bonauer, A. & Dimmeler, S. (2009). The microRNA-17-92 cluster: still a miRacle? Cell Cycle 8, 3866-3873.
5. Burnside, J. & Morgan, R. W. (2007). Genomics and Marek's disease virus. Cytogenet Genome Res 117, 376-387.
6. Dölken, L, Pfeffer, S. & Koszinowski, U. H. (2009). Cytomegalovirus microRNAs. Virus Genes 38, 355-364.
7. Everett, R. D. & Murray, J. (2005). ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol 79, 5078-5089.
8. Fannin Rider, P. J., Dunn, W., Yang, E. & Liu, F. (2008). Human cytomegalovirus microRNAs. Curr Top Microbiol Immunol 325, 21-39.
9. Garzon, R. & Croce, C. M. (2008). MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 15, 352-358.
10. Goodrum, F. D., Jordan, C. T., High, K. & Shenk, T. (2002). Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci U S A 99, 16255-16260.
11. Goodrum, F., Reeves, M., Sinclair, J., High, K. & Shenk, T. (2007). Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110, 937-945.
12. Grey, F. & Nelson, J. (2008). Identification and function of human cytomegalovirus microRNAs. J Clin Virol 41, 186-191.
13. Grey, F., Hook, L. & Nelson, J. (2008). The functions of herpesvirusencoded microRNAs. Med Microbiol Immunol (Berl) 197, 261-267.
14. Griffin, C., Wang, E. C., McSharry, B. P., Rickards, C., Browne, H., Wilkinson, G. W. & Tomasec, P. (2005). Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. J Gen Virol 86, 2999-3008.
15. Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. (2010). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840.
16. Hahn, G., Jores, R. & Mocarski, E. S. (1998). Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A 95, 3937-3942.
17. Hertel, L., Lacaille, V. G., Strobl, H., Mellins, E. D. & Mocarski, E. S. (2003). Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol 77, 7563-7574.
18. Jenkins, C., Abendroth, A. & Slobedman, B. (2004). A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 78, 1440-1447.
19. Jonuleit, H., Adema, G. & Schmitt, E. (2003). Immune regulation by regulatory T cells: implications for transplantation. Transpl Immunol 11, 267-276.
20. Jopling, C. L. (2008). Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans 36, 1220-1223.
21. Jovanovic, M. & Hengartner, M. O. (2006). miRNAs and apoptosis: RNAs to die for. Oncogene 25, 6176-6187.
22. Kerr, M. K., Martin, M. & Churchill, G. A. (2000). Analysis of variance for gene expression microarray data. J Comput Biol 7, 819-837.
23. Kondo, K. & Mocarski, E. S. (1995). Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis Suppl 99, 63-67.
24. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M. & Stoffel, M. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689.
25. Lakshmipathy, U., Love, B., Adams, C., Thyagarajan, B. & Chesnut, J. D. (2007). Micro RNA profiling: an easy and rapid method to screen and characterize stem cell populations. Methods Mol Biol 407, 97-114.
26. Lu, S. & Cullen, B. R. (2004). Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis. J Virol 78, 12868-12876.
27. Meister, G., Landthaler, M., Dorsett, Y. & Tuschl, T. (2004). Sequencespecific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10, 544-550.
28. Murphy, E., Rigoutsos, I., Shibuya, T. & Shenk, T. E. (2003). Reevaluation of human cytomegalovirus coding potential. Proc Natl Acad Sci U S A 100, 13585-13590.
29. Niu, B. X., Teng, L. Q. & Wei, P. (2009). [Marek's disease virus encoded miRNAs - an update review]. Bing Du Xue Bao 25, 154-158 (in Chinese).
30. Omoto, S., Ito, M., Tsutsumi, Y., Ichikawa, Y., Okuyama, H., Brisibe, E. A., Saksena, N. K. & Fujii, Y. R. (2004). HIV-1 nef suppression by virally encoded microRNA. Retrovirology 1, 44.
31. Pan, X., Minegishi, N., Harigae, H., Yamagiwa, H., Minegishi, M., Akine, Y. & Yamamoto, M. (2000). Identification of human GATA-2 gene distal IS exon and its expression in hematopoietic stem cell fractions. J Biochem 127, 105-112.
32. Pfeffer, S. (2007). Identification of virally encoded microRNAs. Methods Enzymol 427, 51-63.
33. Pfeffer, S., Zavolan, M., Grässer, F. A., Chien, M., Russo, J. J., Ju, J., John, B., Enright, A. J., Marks, D. & other authors (2004). Identification of virus-encoded microRNAs. Science 304, 734-736.
34. Pfeffer, S., Sewer, A., Lagos-Quintana, M., Sheridan, R., Sander, C., Grässer, F. A., van Dyk, L. F., Ho, C. K., Shuman, S. & other authors (2005). Identification of microRNAs of the herpesvirus family. Nat Methods 2, 269-276.
35. Poole, E., King, C. A., Sinclair, J. H. & Alcami, A. (2006). The UL144 gene product of human cytomegalovirus activates NFkB via a TRAF6-dependent mechanism. EMBO J 25, 4390-4399.
36. Poole, E., Atkins, E., Nakayama, T., Yoshie, O., Groves, I., Alcami, A. & Sinclair, J. (2008). NF-kB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86. J Virol 82, 4250-4256.
37. Reeves, M. B. & Sinclair, J. H. (2010). Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J Gen Virol 91, 599-604.
38. Reeves, M. B., Lehner, P. J., Sissons, J. G. & Sinclair, J. H. (2005a). An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J Gen Virol 86, 2949-2954.
39. Reeves, M. B., MacAry, P. A., Lehner, P. J., Sissons, J. G. & Sinclair, J. H. (2005b). Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A 102, 4140-4145.
40. Roback, J. D., Hillyer, C. D., Drew, W. L., Laycock, M. E., Luka, J., Mocarski, E. S., Slobedman, B., Smith, J. W., Soderberg-Naucler, C. & other authors (2001). Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion 41, 1249-1257.
41. Rook, A. H. (1988). Interactions of cytomegalovirus with the human immune system. Rev Infect Dis 10 (Suppl. 3), S460-S467.
42. Samols, M. A., Hu, J., Skalsky, R. L. & Renne, R. (2005). Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 79, 9301-9305.
43. Sanjabi, S., Zenewicz, L. A., Kamanaka, M. & Flavell, R. A. (2009). Anti-inflammatory and pro-inflammatory roles of TGF-b, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9, 447-453.
44. Shin, H. D., Park, B. L., Kim, L. H., Jung, J. H., Kim, J. Y., Yoon, J. H., Kim, Y. J. & Lee, H.-S. (2003). Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 12, 901-906.
45. Sinclair, J. (2008). Human cytomegalovirus: latency and reactivation in the myeloid lineage. J Clin Virol 41, 180-185.
46. Spencer, J. V., Cadaoas, J., Castillo, P. R., Saini, V. & Slobedman, B. (2008). Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology 374, 164-169.
47. Stern-Ginossar, N., Gur, C., Biton, M., Horwitz, E., Elboim, M., Stanietsky, N., Mandelboim, M. & Mandelboim, O. (2008). Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol 9, 1065-1073.
48. Stern-Ginossar, N., Saleh, N., Goldberg, M. D., Prichard, M., Wolf, D. G. & Mandelboim, O. (2009). Analysis of human cytomegalovirusencoded microRNA activity during infection. J Virol 83, 10684-10693.
49. Sullivan, C. S., Grundhoff, A. T., Tevethia, S., Pipas, J. M. & Ganem, D. (2005). SV40-encoded microRNAs regulate viral gene expression andreduce susceptibility to cytotoxic T cells. Nature 435, 682-686.
50. Sullivan, C. S., Grundhoff, A., Tevethia, S., Treisman, R., Pipas, J. M. & Ganem, D. (2006). Expression and function of microRNAs in viruses great and small. Cold Spring Harb Symp Quant Biol 71, 351-356.
51. Swaminathan, S. (2008). Noncoding RNAs produced by oncogenic human herpesviruses. J Cell Physiol 216, 321-326.
52. Tang, S., Bertke, A. S., Patel, A., Wang, K., Cohen, J. I. & Krause, P. R. (2008). An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proc Natl Acad Sci U S A 105, 10931-10936.
53. Tang, S., Patel, A. & Krause, P. R. (2009). Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs.J Virol 83, 1433-1442.
54. Teobald, I., Dunnion, D. J., Whitbread, M., Curnow, S. J. & Browning, M. J. (2008). Phenotypic and functional differentiation of KG-1 intodendritic-like cells. Immunobiology 213, 75-86.
55. Tomari, Y. & Zamore, P. D. (2005). Perspective: machines for RNAi. Genes Dev 19, 517-529.
56. Triboulet, R., Mari, B., Lin, Y.-L., Chable-Bessia, C., Bennasser, Y., Lebrigand, K., Cardinaud, B., Maurin, T., Barbry, P. & other authors (2007). Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315, 1579-1582.
57. Wang, F.-Z., Weber, F., Croce, C., Liu, C.-G., Liao, X. & Pellett, P. E. (2008). Human cytomegalovirus infection alters the expression of cellular microRNA species that affect its replication. J Virol 82, 9065-9074.
58. Weber-Nordt, R. M., Henschler, R., Schott, E., Wehinger, J., Behringer, D., Mertelsmann, R. & Finke, J. (1996). Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells. Blood 88, 2549-2558.